FindTrial
Sign In

Everolimus eluting stent

DEVICE7 trials

Sponsors

Catholic University of the Sacred Heart, Yonsei University, San Giuseppe Moscati Hospital, Fondazione Ricerca e Innovazione Cardiovascolare ETS

Conditions

Acute Coronary SyndromeAcute Myocardial InfarctionCoronary Artery DiseaseCoronary Artery StenosisCoronary StenosisMyocardial InfarctionST Elevation Acute Myocardial Infarction

Phase 4

SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis
CompletedNCT00697372
Catholic University of the Sacred HeartCoronary Artery Disease, Coronary Stenosis
Start: 2007-09-30End: 2010-04-30Updated: 2010-06-15
Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis
CompletedNCT01200693
Catholic University of the Sacred HeartCoronary Artery Disease, Coronary Stenosis
Start: 2008-11-30End: 2012-03-31Updated: 2013-02-15
Efficacy of Everolimus-Eluting Versus Zotarolimus-Eluting Sten for Coronary Lesions in Acute Myocardial Infarction
CompletedNCT01347554
Yonsei UniversityMyocardial Infarction
Start: 2009-01-31End: 2013-03-31Updated: 2014-09-29
Everolimus Stent in Myocardial Infarction
CompletedNCT01684982
San Giuseppe Moscati HospitalAcute Myocardial Infarction
Start: 2007-04-30End: 2012-06-30Updated: 2013-04-04
Early Effects of Intensive Lipid Lowering Treatment With Ezetimibe/ Simvastatin (Vytorin®) Assessed by Virtual Histology-Intravascular Ultrasound (VH-IVUS) and Optical Coherence Tomography (OCT) on Plaque Characteristics in Patients With Acute Coronary Syndrome
CompletedNCT01857843
Yonsei UniversityAcute Coronary Syndrome
Start: 2009-11-30End: 2014-01-31Updated: 2014-02-05
Bioresorbable Vascular Scaffold in Patients With Myocardial Infarction
CompletedNCT02151929
San Giuseppe Moscati HospitalST Elevation Acute Myocardial Infarction
Start: 2013-05-31End: 2014-04-30Updated: 2014-06-02

Unknown Phase

Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
Active, not recruitingNCT04893291
Fondazione Ricerca e Innovazione Cardiovascolare ETSCoronary Artery Disease, Coronary Artery Stenosis
Start: 2021-11-16End: 2030-08-30Target: 1820Updated: 2026-02-19

Related Papers

Sirolimus‐coated balloon versus everolimus‐eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial
Catheterization and Cardiovascular Interventions2022-09-0247 citations
Randomized comparison of everolimus-eluting stents and sirolimus-eluting stents in patients with ST elevation myocardial infarction: RACES-MI trial.
2014-08-0130 citations
Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach.
2011-03-0149 citations